Impact of Serum Albumin Levels on Contrast-Induced Acute Kidney Injury in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Intervention
Restricted accessResearch articleFirst published online September, 2015
Impact of Serum Albumin Levels on Contrast-Induced Acute Kidney Injury in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Intervention
Patients with acute coronary syndromes (ACSs) undergoing percutaneous coronary intervention (PCI) are at high risk of contrast-induced acute kidney injury (CI-AKI), a complication associated with poor clinical outcomes. Serum albumin (SA) levels are associated with cardiovascular mortality. We assessed the association between SA levels and the risk of CI-AKI in patients with ACS (n = 890) treated with PCI. Patients were divided into 2 groups: patients with and without CI-AKI. Contrast-induced acute kidney injury was defined as an increase in serum creatinine (≥25% or ≥0.5 mg/dL) from baseline occurring 72 hours after PCI. The SA levels were significantly lower in patients with CI-AKI than in those without CI-AKI (3.52 ± 0.40 vs 3.94 ± 0.39 mg/dL, P < .001). On multivariate analysis, SA was an independent predictor of CI-AKI (odds ratio 0.177, 95% confidence interval 0.080-0.392, P < .001) together with age, female gender, creatine kinase-myocardial band, and glomerular filtration rate. Baseline SA levels are inversely associated with CI-AKI after PCI for ACS.
MehranRAymongEDNikolskyE. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44
(7):1393–1399.
2.
SenooTMotohiroMKamihataH. Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol. 2010;105
(5):624–628.
3.
GoldenbergIMatetzkyS. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ. 2005;172
(11):1461–1471.
4.
HeymanSNRosenSKhamaisiMIdeeJMRosenbergerC. Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy. Invest Radiol. 2010;45
(4):188–195.
5.
TumlinJStaculFAdamA. CIN Consensus Working Panel. Pathophysiology of contrast-induced nephropathy. Am J Cardiol. 2006;98
(6A):14K–20K.
6.
LazarosGTsiachrisDTousoulisD. In-hospital worsening renal function is an independent predictor of one-year mortality in patients with acute myocardial infarction. Int J Cardiol. 2012;155
(1):97–101.
7.
BartholomewBAHarjaiKJDukkipatiS. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol. 2004;93
(12):1515–1519.
8.
FoxCSMuntnerPChenAYAlexanderKPRoeMTWiviottSD. Short-term outcomes of acute myocardial infarction in patients with acute kidney injury: a report from the national cardiovascular data registry. Circulation. 2012;125
(3):497–504.
9.
NarulaAMehranRWeiszG. Contrast induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy. Eur Heart J. 2014;35
(23):1533–1540.
10.
PetersTJrSerum albumin. Adv Protein Chem. 1985;37:161–245.
11.
DonBRKaysenG. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004;17
(6):432–437.
12.
CesariMPenninxBWNewmanAB. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation. 2003;108
(19):2317–2322.
13.
JolesJAWillekes-KoolschijnNKoomansHA. Hypoalbuminemia causes high blood viscosity by increasing red cell lysophosphatidylcholine. Kidney Int. 1997;52
(3):761–770.
14.
RocheMRondeauPSinghNRTarnusEBourdonE. The antioxidant properties of serum albumin. FEBS Lett. 2008;582
(13):1783–1787.
15.
BourdonEBlacheD. The importance of proteins in defense against oxidation. Antioxid Redox Signal. 2001;3
(2):293–311.
16.
PhillipsAShaperAGWhincupPH. Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet1989;2
(8677):1434–1436.
17.
KullerLHEichnerJEOrchardTJGranditsGAMcCallumLTracyRP. The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1991;134
(11):1266–1277.
18.
GillumRFMakucDM. Serum albumin, coronary heart disease, and death. Am Heart J. 1992;123
(2):507–513.
19.
SchalkBWVisserMBremmerMAPenninxBWBouterLMDeegDJ. Change of serum albumin and risk of cardiovascular disease and all-cause mortality: Longitudinal Aging Study Amsterdam. Am J Epidemiol. 2006;164
(10):969–977.
20.
OduncuVErkolAKarabayCY. The prognostic value of serum albumin levels on admission in patients with acute ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention. Coron Artery Dis. 2013;24
(2):88–94.
21.
KurtulAOcekAHMuratSN. Serum albumin levels on admission are associated with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Angiology. 2015;66
(3):278–285.
22.
MikhailidisDPGanotakisES. Plasma albumin and platelet function: relevance to atherogenesis and thrombosis. Platelets. 1996;7
(3):125–137.
23.
AzabBBibawyJHarrisK. Value of albumin–globulin ratio as a predictor of all-cause mortality after non-ST elevation myocardial infarction. Angiology. 2013;64
(2):137–145.
24.
LeveyASBoschJPLewisJBGreeneTRogersNRothD. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130
(6):461–470.
25.
JaraiRDangasGHuberK. B-type natriuretic peptide and risk of contrast-induced acute kidney injury in acute ST-segment-elevation myocardial infarction: a substudy from the HORIZONS-AMI trial. Circ Cardiovasc Interv. 2012;5
(6):813–820.
26.
LaskeyWKJenkinsCSelzerF. NHLBI Dynamic Registry Investigators. Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. J Am Coll Cardiol. 2007;50
(7):584–590.
27.
BörekçiAGürMTürkoğluC. Oxidative stress and paraoxonase 1 activity predict contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Angiology. 2015;66
(4):339–345.
28.
HartopoABGhariniPPSetiantoBY. Low serum albumin levels and in-hospital adverse outcomes in acute coronary syndrome. Int Heart J. 2010;51
(4):221–226.
29.
NicholsonJPWolmaransMRParkGR. The role of albumin in critical illness. Br J Anaesth. 2000;85
(4):599–610.
30.
ZhangWJFreiB. Albumin selectively inhibits TNF alpha-induced expression of vascular cell adhesion molecule-1 in human aortic endothelial cells. Cardiovasc Res. 2002;55
(4):820–829.
31.
LiuYTanNZhouYL. High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention. J Nephrol. 2012;25
(3):332–340.
32.
GünebakmazODuranMKarakayaE. Increased serum asymmetric dimethylarginine level is an independent predictor of contrast-induced nephropathy. Turk Kardiyol Dern Ars. 2013;41
(7):581–588.
33.
ArtuncFHFischerIURislerTErleyCM. Improved estimation of GFR by serum cystatin C in patients undergoing cardiac catheterization. Int J Cardiol. 2005;102
(2):173–178.
